Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Mol Med Rep ; 17(3): 4688-4694, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29344666

RESUMO

Hypohidrotic ectodermal dysplasia (HED), also known as anhidrotic ectodermal dysplasia, is characterized by the clinical manifestations of less sweat or no sweat, sparse or no hair, tooth agenesis and/or abnormal tooth morphology. The characteristics of alpaca ear hair differ from the back hair. The ectodysplasin A (EDA) signaling pathway has a regulatory effect on skin development and hair growth. The aim of the present study was to study the effects of EDA on alpaca hair growth by examining the mRNA and protein expression levels of EDA in alpaca ear and back skin by reverse transcription­quantitative polymerase chain reaction and western blot analysis, respectively. Results indicated that EDA expression was higher in the ear skin compared with the back skin. The expression levels of let­7b in the skin of healthy alpacas varies; the difference between let­7b expression levels of the ear and back have been reported to be >2­fold, suggesting a role for let­7b in the development of adult alpaca skin and hair follicles. A dual­luciferase reporter vector was constructed to verify the targeting relationship between microRNA let­7b and EDA, and the results revealed that EDA was a target gene of let­7b. Alpaca skin fibroblasts were transfected with a let­7b eukaryotic expression vector to investigate the regulatory relationship between let­7b and EDA. The expression of EDA was decreased in the transfected group; immunocytochemical results demonstrated that the EDA protein was abundantly expressed in the fibroblast cytoplasm. EDA protein expression was weaker in the transfected cells than in the untransfected cells. These results suggested that EDA may serve a role in alpaca hair growth and is probably a target gene of let­7b; let­7b downregulated EDA mRNA and protein expressions, which suggested that let­7b may regulate alpaca hair growth. These conclusions suggested that let­7b may be associated with HED.


Assuntos
Ectodisplasinas/metabolismo , Folículo Piloso/metabolismo , MicroRNAs/metabolismo , Regiões 3' não Traduzidas , Animais , Sequência de Bases , Camelídeos Americanos/genética , Camelídeos Americanos/metabolismo , Regulação para Baixo , Fibroblastos/citologia , Fibroblastos/metabolismo , Células HEK293 , Folículo Piloso/crescimento & desenvolvimento , Humanos , Imuno-Histoquímica , Masculino , MicroRNAs/genética , Pele/metabolismo
2.
Acta Histochem ; 114(8): 773-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22521245

RESUMO

It is well recognized that the Wnt pathway, in which ß-catenin and Lef-1 are important factors, is associated with many physiological processes, including embryogenesis and postnatal development. The Wnt pathway also plays a critical role in the development of skin. It regulates the formation of the dorsal dermis and epidermal appendages in the skin and the activity of epithelial stem cells. In this study, we investigated the presence and localization of ß-catenin and Lef-1 in murine hair follicles through the first postnatal month, which encompasses the first hair cycle in mice, using Western blotting and immunohistochemistry. Our results show that ß-catenin and Lef-1 are expressed during all stages in a hair cycle, most strongly in the anagen and weakly in the catagen and telogen phases. The results also suggest that the ß-catenin-Lef-1 complex may regulate hair follicle cycling. This process will be of considerable interest to future studies.


Assuntos
Folículo Piloso/química , Folículo Piloso/crescimento & desenvolvimento , Fator 1 de Ligação ao Facilitador Linfoide/análise , beta Catenina/análise , Animais , Folículo Piloso/metabolismo , Imuno-Histoquímica , Fator 1 de Ligação ao Facilitador Linfoide/metabolismo , Camundongos , Camundongos Endogâmicos , beta Catenina/metabolismo
3.
Epilepsia ; 51(3): 391-403, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19694794

RESUMO

PURPOSE: Past work has demonstrated that kainic acid (KA)-induced seizures could cause the enhancement of excitation and lead to neuronal death in rat hippocampus. To counteract such an imbalance between excitation and inhibition, we designed experiments by activating the inhibitory gamma-aminobutyric acid (GABA) receptor to investigate whether such activation suppresses the excitatory glutamate signaling induced by KA and to elucidate the underlying molecular mechanisms. METHODS: Muscimol coapplied with baclofen was intraperitoneally administrated to the rats 40 min before KA injection by intracerebroventricular infusion. Subsequently we used a series of methods including immunoprecipitation, immunoblotting, histologic analysis, and immunohistochemistry to analyze the interaction, expression, and phosphorylation of relevant proteins as well as the survival of the CA1/CA3 pyramidal neurons. RESULTS: Coadministration of muscimol and baclofen exerted neuroprotection against neuron death induced by KA; inhibited the increased assembly of the GluR6-PSD-95-MLK3 module induced by KA; and suppressed the activation of MLK3, MKK7, and JNK3. DISCUSSION: Taken together, we demonstrate that coactivation of the inhibitory GABA receptors can attenuate the excitatory JNK3 apoptotic signaling pathway via inhibiting the increased assembly of the GluR6-PSD-95-MLK3 signaling module induced by KA. This provides a new insight into the therapeutic approach to epileptic seizure.


Assuntos
Apoptose/efeitos dos fármacos , Baclofeno/farmacologia , Agonistas GABAérgicos/farmacologia , Proteína Quinase 10 Ativada por Mitógeno/efeitos dos fármacos , Muscimol/farmacologia , Receptores de GABA/efeitos dos fármacos , Convulsões/metabolismo , Animais , Apoptose/fisiologia , Modelos Animais de Doenças , Proteína 4 Homóloga a Disks-Large , Humanos , Imuno-Histoquímica , Peptídeos e Proteínas de Sinalização Intracelular/efeitos dos fármacos , Ácido Caínico/farmacologia , MAP Quinase Quinase Quinases/metabolismo , Masculino , Proteínas de Membrana/metabolismo , Proteína Quinase 10 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 10 Ativada por Mitógeno/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de GABA/metabolismo , Receptores de GABA-A/efeitos dos fármacos , Receptores de Ácido Caínico/efeitos dos fármacos , Convulsões/induzido quimicamente , Receptor de GluK2 Cainato
4.
FEBS Lett ; 582(13): 1894-900, 2008 Jun 11.
Artigo em Inglês | MEDLINE | ID: mdl-18498770

RESUMO

Hematopoietic progenitor kinase 1 (HPK1) is a hematopoietic cell-restricted member of the Ste20 serine/threonine kinase super family. We recently reported that HPK1 is involved in c-Jun NH2-terminal kinase (JNK) signaling pathway by sequential activation of MLK3-MKK7-JNK3 after cerebral ischemia. Here, we used 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP2) and MK801 to investigate the events upstream of HPK1 in ischemic brain injury. Immunoprecipitation and immunoblot results showed that PP2 and MK801 significantly decreased the activation of Src, HPK1, MLK3, JNK3 and c-Jun, respectively, during ischemia/reperfusion. Histology and TUNEL staining showed PP2 or MK801 protects against neuron death after brain ischemia. We speculate that this unique signaling pathway through the tyrosine phosphorylation of HPK1 promotes ischemic brain injury by activated Src via N-methyl-d-aspartate receptor and, ultimately, the activation of the MLK3-MKK7-JNK3 pathway after cerebral ischemia.


Assuntos
Isquemia Encefálica/enzimologia , Hipocampo/enzimologia , Proteínas Serina-Treonina Quinases/metabolismo , Tirosina/metabolismo , Quinases da Família src/metabolismo , Animais , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/patologia , Citoproteção , Maleato de Dizocilpina/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , MAP Quinase Quinase Quinases/antagonistas & inibidores , MAP Quinase Quinase Quinases/metabolismo , Masculino , Proteína Quinase 10 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 10 Ativada por Mitógeno/metabolismo , Fármacos Neuroprotetores/farmacologia , Fosforilação , Inibidores de Proteínas Quinases/farmacologia , Pirimidinas/farmacologia , Ratos , Ratos Sprague-Dawley , Traumatismo por Reperfusão/enzimologia , Traumatismo por Reperfusão/patologia , Transdução de Sinais , Quinases da Família src/antagonistas & inibidores , MAP Quinase Quinase Quinase 11 Ativada por Mitógeno
5.
Neuroreport ; 19(6): 647-51, 2008 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-18382279

RESUMO

In this study, we investigated the role of hematopietic progenitor kinase 1 (HPK1) in delayed neuronal damage after cerebral ischemia and the possible regulatory mechanisms of this event. Our data show that tyrosine phosphorylation of HPK1 was significantly increased at 6 h of ischemic-reperfusion compared with sham control. The increase in p-HPK1, p-MLK3, p-MKK7, and p-JNK3 was attenuated by HPK1 antisense oligodeoxynucleotides intra-cerebroventricular infusion, but not MS-ODNs or vehicle. Intracerebroventricular infusion of antisense oligodeoxynucleotides also increased the number of surviving pyramidal neurons, whereas MS-ODNs or vehicle (TE) groups had no effects. These results indicate that knockdown of HPK1 expression provides neuroprotection through downregulation activation of the MLK3-MKK7-JNK3 pathway following cerebral ischemia in the rat hippocampus CA1 subfield.


Assuntos
Encéfalo/metabolismo , Hipóxia-Isquemia Encefálica/metabolismo , Degeneração Neural/metabolismo , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Transdução de Sinais/fisiologia , Animais , Western Blotting , Ativação Enzimática/fisiologia , Imunoprecipitação , MAP Quinase Quinase 7/metabolismo , MAP Quinase Quinase Quinases/metabolismo , Masculino , Proteína Quinase 10 Ativada por Mitógeno/metabolismo , Oligodesoxirribonucleotídeos Antissenso , Fosforilação , Proteínas Serina-Treonina Quinases/genética , Ratos , Ratos Sprague-Dawley , MAP Quinase Quinase Quinase 11 Ativada por Mitógeno
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA